FDA Cites Cargill for Violations at Feed Production Facility
Inspection at Cleveland, NC, facility occurred after company's voluntary recall of multiple food products
The U.S. Food and Drug Administration (FDA) published a letter on Tuesday outlining how it had identifed regulation non-compliance at a Cargill facility in Cleveland, NC, in several inspections it conducted in June 2019.
The inspections occurred after Cargill voluntarily recalled several animal feed products in May 2019 due to the presence of aflatoxin at levels that exceed FDA’s action level for the intended uses.
The FDA inspection revealed violations of the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Food for Animals requirements.
In addition, the inspection revealed violations of the Current Good Manufacturing Practice (CGMP) requirements for medicated feeds.
Cargill has 15 days following the receipt of the letter to identify specific steps it has taken to correct violations.